FLEXIBLE-DOSE VARDENAFIL IN A COMMUNITY-BASED POPULATION OF MEN AFFECTED BY ERECTILE DYSFUNCTION: A 12-WEEK OPEN-LABEL, MULTICENTER TRIAL.